Aiforia selected to provide AI-assisted diagnostic solutions to regional health authorities in Italy

Aiforia Technologies Plc PRESS RELEASE January 24, 2025 at 3.45 p.m. EET

The Lombardy region health authorities in Italy have selected Aiforia Technologies Plc as their partner for AI-assisted image analysis for clinical diagnostics in pathology. The collaboration involves using Aiforia's clinical AI solutions to analyze biopsies from breast, lung, and prostate cancer patients and its AI model development software. 

The three-year contract is part of an initiative to digitize the anatomical pathology laboratories of 31 health authorities in the Lombardy region, including AI solutions for image analysis. The provider in the won tender is a GPI S.p.A. lead consortium, and Aiforia is one of their subcontractors.

"This collaboration marks a significant milestone for Aiforia. After the first successful large regional digital pathology project in the Veneto region in Italy, this proves that Aiforia's AI solutions have a strong foothold in the digitalization of healthcare in Italy and in improving the efficiency and accuracy of pathology image analysis. At the same time, the contract strengthens our position in the European digital pathology market," says Jukka Tapaninen, CEO of Aiforia.

Lombardy is the largest metropolitan area and the most populous region in northern Italy, with 10 million inhabitants. The center of the area is Milan. 

Further inquiries:
Jukka Tapaninen, CEO, Aiforia Technologies Plc
tel. +33 61 041 6686
https://investors.aiforia.com/

Certified Adviser
UB Corporate Finance Ltd
ubcf@unitedbankers.fi

About Aiforia

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.

Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.

Find out more at www.aiforia.com